Chopin C, Vallet B, Mehdaoui H
Service de Réanimation polyvalente, Hôpital B, Centre Hospitalier universitaire de Lille.
Chirurgie. 1992;118(10):621-7.
From previous studies it has been hypothesized that multiple organ failure and high level of mortality, seen in critically ill septic patients, may be due to defective oxygen extraction and tissue hypoxia occurring early in the course of sepsis. Oxygen flux test has been proposed as a method of revealing an occult oxygen debt. We used a one hour dobutamine infusion test, in septic patients, without increase in blood lactate. Fifty patients with sepsis syndrome entered a multicentric prospective study. After fluid loading to increase pulmonary artery occlusion pressure (Paop) to a minimum value of 10 mmHg, all the patients were given 10 mcg/kg.min of dobutamine for one hour. Hemodynamic and metabolic variables were recorded before, HO, and after the test, H1 (cardiac index, Paop, oxygen deliver, DO2, and consumption, VO2, oxygen extraction ratio, (OER), blood lactate). The dobutamine test allowed to identify responders (R) who increased VO2 by more than 15% and non-responders. R and NR differed significantly in mortality (8.5% vs 44.4%). The test has a good predictive value for surviving. Without respect of the result of the test, the patients were randomized in two groups. The group D+ was given conventional therapy and dobutamine at the same rate of infusion for 9 consecutive days and the D- group received only conventional therapy. The RD+ patients improved more rapidly when compared with RD-, NRD+, NRD-. We concluded that a one hour dobutamine test is able to identify R and NR critically ill septic patients. The response is associated with significant difference in outcome.(ABSTRACT TRUNCATED AT 250 WORDS)
以往的研究推测,重症脓毒症患者出现的多器官功能衰竭和高死亡率,可能是由于脓毒症病程早期发生的氧摄取缺陷和组织缺氧所致。氧通量测试已被提议作为一种揭示隐匿性氧债的方法。我们对脓毒症患者进行了1小时的多巴酚丁胺输注试验,且未使血乳酸增加。50例脓毒症综合征患者进入了一项多中心前瞻性研究。在进行液体负荷以使肺动脉闭塞压(Paop)升高至最低10 mmHg后,所有患者均接受10 mcg/kg.min的多巴酚丁胺输注1小时。在试验前(HO)、试验后(H1)记录血流动力学和代谢变量(心脏指数、Paop、氧输送量DO2、氧消耗量VO2、氧摄取率OER、血乳酸)。多巴酚丁胺试验能够识别VO2增加超过15%的反应者(R)和无反应者。反应者和无反应者在死亡率方面有显著差异(8.5%对44.4%)。该试验对存活有良好的预测价值。无论试验结果如何,患者被随机分为两组。D+组接受常规治疗并以相同输注速率连续9天给予多巴酚丁胺,D-组仅接受常规治疗。与RD-、NRD+、NRD-组相比,RD+组患者改善更快。我们得出结论,1小时的多巴酚丁胺试验能够识别重症脓毒症患者中的反应者和无反应者。这种反应与预后的显著差异相关。(摘要截选至250字)